Rupintrivir
≥98% (HPLC)
- Product Code: 123108
CAS:
223537-30-2
| Molecular Weight: | 598.66 g./mol | Molecular Formula: | C₃₁H₃₉FN₄O₇ |
|---|---|---|---|
| EC Number: | MDL Number: | MFCD13185163 | |
| Melting Point: | 170-171°C | Boiling Point: | |
| Density: | Storage Condition: | room temperature |
Product Description:
Rupintrivir is primarily researched for its antiviral properties, particularly in targeting picornaviruses, which include pathogens like rhinovirus and enterovirus. It functions as a protease inhibitor, disrupting viral replication by blocking the activity of the 3C protease enzyme essential for viral protein processing. This mechanism makes it a potential candidate for treating respiratory infections caused by rhinoviruses, such as the common cold, and more severe conditions like enterovirus-induced myocarditis or meningitis. Its application is largely experimental, with studies focusing on its efficacy, safety, and potential for development into a therapeutic antiviral drug.
Product Specification:
| Test | Specification |
|---|---|
| Appearance | White To Beige Powder |
| Purity (%) | 97.5-100 |
| Solubility | DMSO: 25 mg/mL, Clear |
| Infrared Spectrum | Conforms To Structure |
| NMR | Conforms To Structure |
Sizes / Availability / Pricing:
| Size (g) | Availability | Price | Quantity |
|---|---|---|---|
| 0.001 | 10-20 days | €162.25 |
+
-
|
Rupintrivir
Rupintrivir is primarily researched for its antiviral properties, particularly in targeting picornaviruses, which include pathogens like rhinovirus and enterovirus. It functions as a protease inhibitor, disrupting viral replication by blocking the activity of the 3C protease enzyme essential for viral protein processing. This mechanism makes it a potential candidate for treating respiratory infections caused by rhinoviruses, such as the common cold, and more severe conditions like enterovirus-induced myocarditis or meningitis. Its application is largely experimental, with studies focusing on its efficacy, safety, and potential for development into a therapeutic antiviral drug.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Cart
No products
Subtotal:
€0.00
€0.00
Total :